Abbott’s submits supplemental approval application for Lupron Depot to FDA
ABBOTT PARK, Ill. Abbott is hoping that the Food and Drug Administration will approve one of its drugs as a treatment for advanced prostate cancer.
The Chicago-based drug maker announced Thursday that the FDA accepted its supplemental approval application for Lupron Depot (leuprolide acetate) in the 45-mg strength. The drug, an injectable, works by suppressing production of testosterone for six months. It is currently available in 7.5-mg, 22.5-mg and 30-mg formulations that work for one, three and four months.
“For many patients with advanced prostate cancer, Lupron Depot is an important treatment option because it can help manage the symptoms of their disease,” Abbott VP global pharmaceutical development Eugene Sun said in a statement. “Abbott is seeking approval for a new six-month formulation to provide greater convenience and dosing flexibility to physicians and patients who could benefit form this medication.”
Kinney Drugs offering free glucose testing to customers
GOUVERNEUR, N.Y. Kinney Drugs will offer free glucose testing at its stores in Vermont under a partnership with six local hospitals, the regional retail pharmacy chain announced Thursday.
All of Kinney’s stores in Vermont will have a diabetes clinic on March 23 from 11 a.m. to 1 p.m. The clinic includes a test to determine whether customers are at risk, a finger-stick blood glucose test and diabetes education. Customers also will receive free samples and a “How to Live Well with Diabetes” booklet from the Vermont Health Department.
“We are very grateful for the relationship we have with our local community health agencies,” Kinney marketing manager Penny Perrone-Gray said. “Combined with their expertise in the diabetes field and our pharmacists’ medication knowledge, the program will be very informational to those who may be at risk of developing diabetes.”
Berry awarded NACDS Congressional Leadership Award
WASHINGTON During the National Association of Chain Drug Stores 2nd Annual RxIMPACT Day on Capitol Hill, NACDS honored Rep. Marion Berry, D-Ark., with the NACDS Congressional Leadership Award for his strong commitment and lifetime support of pharmacy.
As the only licensed pharmacist in the United States Congress, Rep. Berry has been a champion for pharmacy’s healthcare priorities, from Medicaid average manufacturer price reform to preserving seniors’ access to durable medical equipment such as diabetes testing supplies from neighborhood pharmacies, NACDS said Thursday.
“As over 250 pharmacy advocates descend on Washington, D.C., for RxIMPACT Day to meet with their respective Members of Congress to advance pharmacy’s priorities, it is only fitting we recognize one of our most vocal advocates in Congress –– Representative Marion Berry,” said NACDS president and CEO Steve Anderson. “It is an honor to spotlight one of pharmacy’s true allies on Capitol Hill. Rep. Berry’s commitment, leadership and voice will be missed by pharmacy and by all who are concerned about healthcare delivery.”